← Leaderboards
Alex Jaeger
Massachusetts Institute Of Technology
$2,013,450
Attributed
$2,013,450
Total exposure
3
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $734.5K · FY2020–25$1M$750K$500K$250K$0
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$2,013,450 · 3
By mechanism
R01$970,988 · 1
R00$742,016 · 1
K99$300,446 · 1
Top collaborators
No co-investigators on record.
Most similar at Massachusetts Institute Of Technology
Same institution · by research overlap
- Ronald T Raines$23,937,707
- Steven A. Carr$47,532,757
- Rudolph Emile Tanzi$37,301,297
- Michael B Yaffe$28,748,219
- Robert T Sauer$22,791,263
Others in their field
Other Emerging Leaders on “Mutation”
- Leonard Freedman · Leidos Biomedical Research, Inc.$85,874,322
- John Damon Chodera · Sloan-Kettering Inst Can Research$48,421,310
- Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$38,744,543
- Lynn Briscoe · Leidos Biomedical Research, Inc.$38,032,945
- Maria C Carrillo · Indiana University Indianapolis$19,445,642
- James Dale Berry · Brigham And Women'S Hospital$19,118,191
Research focus
MutationProteinsIn VivoMutatePathway InteractionsPositioning AttributeGenetically Engineered MouseImmunotherapyMediatingMouse ModelDesignNeoantigensPeptidesCancer CellAntigensExperimental StudyAnti-Tumor Immune ResponseImmuneMajor Histocompatibility ComplexMalignant NeoplasmsCd8-Positive T-LymphocytesCellsAntigen PresentationResponse
Grant awards (7)
Interrogating the relationship between translational dynamics and non-canonical antigen presentation in lung cancer$485,494
R01 · FY2025 · CA · contact PI
Interrogating the relationship between translational dynamics and non-canonical antigen presentation in lung cancer$485,494
R01 · FY2024 · CA · contact PI
Exploring the impact of HSP90 inhibition on antigen presentation and anti-tumor immune responses$248,999
R00 · FY2024 · CA · contact PI
Exploring the impact of HSP90 inhibition on antigen presentation and anti-tumor immune responses$248,999
R00 · FY2023 · CA · contact PI
Exploring the impact of HSP90 inhibition on antigen presentation and anti-tumor immune responses$244,018
R00 · FY2022 · CA · contact PI
Exploring the impact of HSP90 inhibition on antigen presentation and anti-tumor immune responses$150,223
K99 · FY2021 · CA · contact PI
Exploring the impact of HSP90 inhibition on antigen presentation and anti-tumor immune responses$150,223
K99 · FY2020 · CA · contact PI